Buyout firms, including Advent International, Blackstone Group (BX), Bain Capital, CVC Capital Partners, EQT AB and KKR (KKR) have interest in Sanofi’s consumer health division ahead of a potential separation of the business, Dinesh Nair, Swetha Gopinath and Manuel Baigorri of Bloomberg report, citing people familiar with the matter. The unit could be valued at about $20B in any deal, sources told Bloomberg. Advisers to Sanofi have communicated that it’s open to a sale of the consumer health business if it can achieve its desired valuation, the people said. Sanofi may retain a stake in the business as part of any agreement, and deliberations are in the early stages, adds Bloomberg.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SNY: